
In January, 2019, GlaxoSmithKline, Teva and Takeda partnered with EcoVadis to launch a Responsible Health Initiative. Their aim is to use technology and collaboration to improve the visibility, efficiency and sustainability impact of the global health supply chain. Through this initiative they will be looking to; harmonize industry standards for online CSR assessments, adopt a common platform to share CSR performance and benchmark and implement shared tools to boost supplier engagement.
About the Author
EcoVadis is a purpose-driven company dedicated to embedding sustainability intelligence into every business decision worldwide. With global, trusted and actionable ratings, businesses of all sizes rely on EcoVadis’ detailed insights to comply with ESG regulations, reduce GHG emissions, and improve the sustainability performance of their business and value chain across 220 industries in 180 countries. Leaders like Johnson & Johnson, L’Oréal, Unilever, Bridgestone, BASF and JPMorgan are among 150,000+ businesses that use EcoVadis ratings, risk, and carbon management tools and e-learning platform to accelerate their journey toward resilience, sustainable growth and positive impact worldwide.
Follow on Linkedin
Visit Website
More Content by EcoVadis EN